EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $6,695,000 | -38.4% | 449,338 | -57.6% | 0.60% | -56.0% |
| Q3 2019 | $10,865,000 | -9.8% | 1,060,043 | -6.7% | 1.37% | +12.7% |
| Q2 2019 | $12,042,000 | -46.0% | 1,136,043 | -28.8% | 1.22% | -40.8% |
| Q1 2019 | $22,307,000 | +37.6% | 1,595,643 | 0.0% | 2.06% | +26.8% |
| Q4 2018 | $16,212,000 | +30.0% | 1,595,643 | +53.5% | 1.62% | +44.3% |
| Q3 2018 | $12,474,000 | -1.6% | 1,039,500 | 0.0% | 1.12% | -6.9% |
| Q2 2018 | $12,682,000 | +4413.2% | 1,039,500 | +7225.6% | 1.21% | +987.4% |
| Q2 2016 | $281,000 | -91.2% | 14,190 | -92.5% | 0.11% | -90.0% |
| Q1 2016 | $3,179,000 | – | 189,545 | – | 1.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |